K

Kiniksa Pharmaceuticals Ltd
D

KNSA

41.600
USD
-0.02
(-0.05%)
مغلق
حجم التداول
10,262
الربح لكل سهم
1
العائد الربحي
-
P/E
92
حجم السوق
3,153,103,574
أصول ذات صلة الأخبار المقالات

العنوان: Kiniksa Pharmaceuticals International plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.